Exploring skin immune cells to create new treatments for psoriasis
Harnessing Human Dendritic Cell Subsets in Skin for the Design of Novel Immunotherapies
This study is looking at special immune cells in the skin that might play a big role in psoriasis, with the goal of finding better treatments that can help you feel better for a longer time and with fewer side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10655421 on NIH RePORTER |
What this research studies
This research investigates the role of specific immune cells called dendritic cells in the skin, particularly focusing on a newly discovered subset that may influence the development of psoriasis. By understanding how these cells activate inflammatory responses, the research aims to design targeted immunotherapies that could provide long-lasting relief for patients suffering from this autoimmune disease. The approach involves studying the interactions between these dendritic cells and T cells, which are crucial in the inflammatory process of psoriasis. Patients may benefit from new treatment options that are more effective and have fewer side effects compared to current therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with psoriasis, particularly those who have not responded well to existing treatments.
Not a fit: Patients with psoriasis who are currently well-managed on existing therapies may not see significant benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted immunotherapies that provide durable relief from psoriasis with minimal side effects.
How similar studies have performed: Other research has shown promise in targeting immune cells for the treatment of autoimmune diseases, suggesting that this approach could be effective.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Klechevsky, Eynav Yafit — Washington University
- Study coordinator: Klechevsky, Eynav Yafit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.